Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Carbonic anhydrase 9 (CA9) is a transmembrane zinc metalloenzyme that catalyzes the reversible hydration of carbon dioxide. It plays a crucial role in regulating pH, particularly in hypoxic tumor microenvironments. CA9's unique structural features and expression pattern make it a promising therapeutic target for cancer treatment.
Inhibition of CA9 enzymatic activity, disruption of CA9 dimerization, or antibody-mediated targeting of CA9 on tumor cells.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Carbonic anhydrase 9 (CA9).